SLGL

Sol-Gel Technologies (SLGL)

About Sol-Gel Technologies (SLGL)

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Details

Daily high
$82.50
Daily low
$77.00
Price at open
$82.50
52 Week High
$97.97
52 Week Low
$4.02
Market cap
222.9M
Dividend yield
0.00%
Volume
23,087
Avg. volume
29,743
P/E ratio
-36.38

Sol-Gel Technologies News

Details

Daily high
$82.50
Daily low
$77.00
Price at open
$82.50
52 Week High
$97.97
52 Week Low
$4.02
Market cap
222.9M
Dividend yield
0.00%
Volume
23,087
Avg. volume
29,743
P/E ratio
-36.38